Literature DB >> 1685646

K-ras oncogene mutations in neoplasias of kidney transplanted patients: preliminary results with a new technique.

G D Skalkeas1, D A Spandidos, A Kostakis, S Balafouta-Tseleni, E Choremi, D Iliopoulos, A Haliassos.   

Abstract

K-ras oncogene activations by point mutations are frequent in many forms of human cancers but there is a special category of cancers occurring in immunosuppressed patients after kidney transplantation in which the frequency of K-ras oncogene activation has not been fully studied. We used a new sensitive and easy method for the detection of this mutation, and in 8 DNA samples studied from various neoplasias of 8 patients after kidney transplantation, we found 4 mutations. Our preliminary results indicate that the activation of K-ras oncogene at codon 12, is a common event among the kidney transplanted patients who present a neoplasia, even in the least aggressive forms of the disease, contrary to the sporadic cases.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1685646

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Ras gene activation in malignant cells of human ovarian carcinoma peritoneal fluids.

Authors:  D N Dokianakis; M N Varras; M Papaefthimiou; J Apostolopoulou; H Simiakaki; E Diakomanolis; D A Spandidos
Journal:  Clin Exp Metastasis       Date:  1999-06       Impact factor: 5.150

2.  Calcineurin inhibitors activate the proto-oncogene Ras and promote protumorigenic signals in renal cancer cells.

Authors:  Dipak Datta; Alan G Contreras; Aninda Basu; Olivier Dormond; Evelyn Flynn; David M Briscoe; Soumitro Pal
Journal:  Cancer Res       Date:  2009-11-10       Impact factor: 12.701

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.